These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29571795)

  • 21. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases.
    Reischauer C; Patzwahl R; Koh DM; Froehlich JM; Gutzeit A
    Sci Rep; 2017 Jul; 7(1):5809. PubMed ID: 28724944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
    Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
    Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging.
    Arita Y; Takahara T; Yoshida S; Kwee TC; Yajima S; Ishii C; Ishii R; Okuda S; Jinzaki M; Fujii Y
    Invest Radiol; 2019 Oct; 54(10):638-644. PubMed ID: 31192827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body MRI: detecting bone metastases from prostate cancer.
    Nakanishi K; Tanaka J; Nakaya Y; Maeda N; Sakamoto A; Nakayama A; Satomura H; Sakai M; Konishi K; Yamamoto Y; Nagahara A; Nishimura K; Takenaka S; Tomiyama N
    Jpn J Radiol; 2022 Mar; 40(3):229-244. PubMed ID: 34693502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).
    Qi WX; Zhang Q; Li P; Zhang XM; Zhang GY; Wu B; Lu JJ; Jiang GL; Fu S
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1361-7. PubMed ID: 27008005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparative study of
    Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
    Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
    Balogova S; Zakoun JB; Michaud L; Khalil A; Tassart M; Esteso A; Kerrou K; Huchet V; Carette MF; Lotz JP; Talbot JN
    Clin Nucl Med; 2014 Nov; 39(11):951-9. PubMed ID: 25140552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperpolarized
    Chen HY; Aggarwal R; Bok RA; Ohliger MA; Zhu Z; Lee P; Gordon JW; van Criekinge M; Carvajal L; Slater JB; Larson PEZ; Small EJ; Kurhanewicz J; Vigneron DB
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):269-276. PubMed ID: 31685983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.
    Vargas HA; Schor-Bardach R; Long N; Kirzner AN; Cunningham JD; Goldman DA; Moskowitz CS; Sosa RE; Sala E; Panicek DM; Hricak H
    Abdom Radiol (NY); 2017 Jan; 42(1):271-277. PubMed ID: 27480976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified values.
    Messiou C; Collins DJ; Morgan VA; Bianchini D; de Bono JS; de Souza NM
    Skeletal Radiol; 2014 Feb; 43(2):205-8. PubMed ID: 24271011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing response in bone metastases in prostate cancer with diffusion weighted MRI.
    Messiou C; Collins DJ; Giles S; de Bono JS; Bianchini D; de Souza NM
    Eur Radiol; 2011 Oct; 21(10):2169-77. PubMed ID: 21710270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer.
    Kanoh Y; Ohtani N; Mashiko T; Ohtani S; Nishikawa T; Egawa S; Baba S; Ohtani H
    Anticancer Res; 2001; 21(1B):551-6. PubMed ID: 11299802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of whole-lesion apparent diffusion coefficient (ADC) first-order statistics and texture features in clinical staging of cervical cancers.
    Guan Y; Li W; Jiang Z; Zhang B; Chen Y; Huang X; Zhang J; Liu S; He J; Zhou Z; Ge Y
    Clin Radiol; 2017 Nov; 72(11):951-958. PubMed ID: 28728757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
    Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted imaging of the abdomen: Impact of b-values on texture analysis features.
    Becker AS; Wagner MW; Wurnig MC; Boss A
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27898201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
    Taue R; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.